Literature DB >> 2972307

Vascular responses to local atrial natriuretic peptide infusion in man.

D J Webb1, N Benjamin, M J Allen, J Brown, M O'Flynn, J R Cockcroft.   

Abstract

1. The effect on skin and muscle blood flow of arterial infusion of atrial natriuretic peptide (ANP) directly into the forearm circulation, and on venous tone of direct infusion into a dorsal hand vein, was studied in normal subjects. 2. ANP produced a dose-dependent increase in both skin and muscle blood flow, but at equivalent doses, produced no dilatation of noradrenaline-preconstricted dorsal hand veins. These findings indicate that ANP acting locally, is an arterioselective dilator in the upper limb circulation in normal man. 3. Measurements of ANP in venous plasma during arterial infusion suggest marked clearance of ANP across the forearm vascular bed. Such peripheral clearance may, at least in part, account for the short plasma half-life of this peptide. 4. The lowest dose of ANP infused was calculated to produce plasma levels similar to those found in patients with heart failure. The findings with this dose suggest that, in heart failure, circulating levels of ANP may be within a range capable of influencing peripheral vascular resistance directly.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2972307      PMCID: PMC1386535          DOI: 10.1111/j.1365-2125.1988.tb05273.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  37 in total

Review 1.  The heart and the atrial natriuretic factor.

Authors:  M Cantin; J Genest
Journal:  Endocr Rev       Date:  1985       Impact factor: 19.871

2.  Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers.

Authors:  A M Richards; M G Nicholls; H Ikram; M W Webster; T G Yandle; E A Espiner
Journal:  Lancet       Date:  1985-03-09       Impact factor: 79.321

3.  In vivo evaluation of signal processors for laser Doppler tissue flowmeters.

Authors:  H Ahn; K Johansson; O Lundgren; G E Nilsson
Journal:  Med Biol Eng Comput       Date:  1987-03       Impact factor: 2.602

4.  Interaction of angiotensin-converting enzyme inhibitors with the function of the sympathetic nervous system.

Authors:  D P Clough; M G Collis; J Conway; R Hatton; J R Keddie
Journal:  Am J Cardiol       Date:  1982-04-21       Impact factor: 2.778

5.  Comparative vasoactive effects of native and synthetic atrial natriuretic factor (ANF).

Authors:  R Garcia; G Thibault; R F Nutt; M Cantin; J Genest
Journal:  Biochem Biophys Res Commun       Date:  1984-03-15       Impact factor: 3.575

6.  Effect of a purified atrial natriuretic factor on rat and rabbit vascular strips and vascular beds.

Authors:  R Garcia; G Thibault; M Cantin; J Genest
Journal:  Am J Physiol       Date:  1984-07

7.  Vasodilator profile of synthetic atrial natriuretic factor.

Authors:  R J Winquist; E P Faison; R F Nutt
Journal:  Eur J Pharmacol       Date:  1984-06-15       Impact factor: 4.432

8.  Failure of atriopeptin II to cause arterial vasodilation in the conscious rat.

Authors:  R W Lappe; J F Smits; J A Todt; J J Debets; R L Wendt
Journal:  Circ Res       Date:  1985-04       Impact factor: 17.367

9.  Atriopeptins: renal-specific vasodilators in conscious dogs.

Authors:  T H Hintze; M G Currie; P Needleman
Journal:  Am J Physiol       Date:  1985-04

10.  Rat atrial natriuretic factor. Purification and vasorelaxant activity.

Authors:  R T Grammer; H Fukumi; T Inagami; K S Misono
Journal:  Biochem Biophys Res Commun       Date:  1983-10-31       Impact factor: 3.575

View more
  8 in total

Review 1.  Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications.

Authors:  I B Wilkinson; D J Webb
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

2.  Intradermal administration of atrial natriuretic peptide has no effect on sweating and cutaneous vasodilator responses in young male adults.

Authors:  Naoto Fujii; Brendan D McNeely; Takeshi Nishiyasu; Glen P Kenny
Journal:  Temperature (Austin)       Date:  2017-10-09

Review 3.  Clinical pharmacology, physiology and pathophysiology of superficial veins--2.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1994-10       Impact factor: 4.335

4.  Beta-adrenoceptor blockade potentiates acute exercise-induced release of atrial natriuretic peptide by increasing atrial diameter in normotensive healthy subjects.

Authors:  I Berlin; P Lechat; G Deray; C Landault; G Maistre; V Chermat; R Brouard; C Ressayre; A J Puech
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Effects of intradermal injection of atrial natriuretic peptide.

Authors:  A M Sharara; M A Higham; A Spanevello; P W Ind
Journal:  Br J Clin Pharmacol       Date:  1995-09       Impact factor: 4.335

6.  Atrial natriuretic peptide decreases hepatic and cardiac blood content, but increases intestinal blood content in supine humans.

Authors:  J Peters; D Neuser; W Schaden; J O Arndt
Journal:  Basic Res Cardiol       Date:  1992 May-Jun       Impact factor: 17.165

7.  Atrial natriuretic peptide alters neither capillary filtration nor vascular compliance of both skin and skeletal muscle of humans.

Authors:  T Rölleke; B Berke; J O Arndt
Journal:  Basic Res Cardiol       Date:  1994 Mar-Apr       Impact factor: 17.165

8.  Increased circulating atrial natriuretic factor concentrations in patients with chronic heart failure after inhibition of neutral endopeptidase: effects on diastolic function.

Authors:  D B Northridge; A Jardine; E Henderson; S G Dilly; H J Dargie
Journal:  Br Heart J       Date:  1992-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.